| Дата випуску | Назва | Автор(и) |
| 2022 | Association of serological status with the frequency of clinical and radiological remission in rheumatoid arthritis | Iaremenko, O.; Mykytenko, G. |
| 2020 | Bone turnover biomarkers, disease activity, and MRI changes of sacroiliac joints in patients with spondyloarthritis | Iaremenko, O.; Shynkaruk, I.; Fedkov, D.; Iaremenko, K.; Petelytska, L. |
| 2021 | Cardiovascular risk in patients with osteoarthritis: results of the all-ukrainian study “PARTNER” | Iaremenko, O.; Volodko, O.; Hrechanyk, N.; Vedenkina, L.; Ahafonova, N.; Brusentseva, S.; Doroshenko, G.; Komkina, M. |
| 2021 | Clinical and immunological characteristics of patients with juvenile-, adult- and late onset systemic lupus erythematosus | Iaremenko, O.; Koliadenko, D.; Matiyashchuk, I. |
| 2020 | Clinical presentation, imaging and response to interferon‑alpha therapy in Erdheim–Chester disease: case‑based review | Iaremenko, O.; Petelytska, L.; Dyadyk, O.; Negria, N.; Fedkov, D. |
| 2022 | Correlation of clinical parameters with urinary collagen type II C-telopeptide and knee cartilage thickness measured with ultrasound in patients with knee osteoarthritis | Iaremenko, O.; Fedkov, D.; Saifullina, M.; Iaremenko, K. |
| 2019-04 | Correlation of DXA with disease duration, changes in sacroiliac joints on magnetic resonance imaging, disease activity and serum levels of sclerostin and dickkopf-1 in patients with spondyloarthritis | Iaremenko, O.; Shynkaruk, I.; Fedkov, D.; Mazanko, K. |
| 2019-06 | Dickkopf-1 serum levels and their correlation with active and chronic MRI-changes of sacroiliac joints and clinical indices in patients with spondyloarthritis | Shynkaruk, I.; Iaremenko, O.; Fedkov, D.; Iaremenko, K. |
| 2022 | Dual energy x-ray absorptiometry in patients with spondyloarthritis. Correlation with disease duration, activity and changes in sacroiliac joints on magnetic resonance imaging | Iaremenko, O.; Fedkov, D.; Mazanko, K. |
| 2019-03 | Factors associated with patient mortality in systemic necrotizing vasculitis | Petelytska, L.; Iaremenko, O. |
| 2021 | Low back pain in men and women without spondyloarthritis | Iaremenko, O.; Mazanko, K.; Fedkov, D.; Dobrianskyi, D.; Smirnova, O.; Zhukova, V. |
| 2019 | Ophthalmic manifestations of IgG4-related disease | Iaremenko, O.; Koliadenko, D. |
| 2019 | Ophthalmological manifestations and endothelin-1 plasma levels in patients with systemic necrotizing vasculitis (SNV) | Petelytska, L.; Iaremenko, O.; Iaremenko, K. |
| 2019-09 | Oral and inhalation usage of acetylcysteine in patients with COPD | Gumeniuk, G.; Kuzmenko, N.; Iaremenko, O.; Dobrianskiy, D.; Ilnytskyi, R. |
| 2021 | Prevalence and clinical associations of neuropsychiatric symptoms among patients with systemic lupus erythematosus | Iaremenko, O.; Koliadenko, D. |
| 2020 | Proteinase 3–antineutrophil cytoplasmic antibody (ANCA)–positive and ANCA–negative or myeloperoxidase–ANCA–positive patients with granulomatosis with polyangiitis: distinct patient subsets | Petelytska, L.; Iaremenko, O. |
| 2022 | Relationship of urinary collagen type II C-telopeptide and knee cartilage thickness measured with ultrasound in patients with knee osteoarthritis | Iaremenko, O.; Fedkov, D.; Saifullina, M.; Sydorova, A.; Iaremenko, K. |
| 2022 | Sex‑related diferences in plasma amino acids of patients with ST‑elevation myocardial infarction and glycine as risk marker of acute heart failure with preserved ejection fraction | Iaremenko, O.; Iordanova, N.; Dudka, P.; Kuchmerovska, T. |
| 2020 | The efficacy and safety of inhaled acetylcysteine in comparison with oral acetylcysteine in chronic obstructive pulmonary disease: A randomized single-center study | Kuzmenko, N.; Iaremenko, O.; Dobrianskiy, D.; Ilnytskyi, R.; Gumeniuk, G. |
| 2020 | The efficacy and safety of inhaled acetylcysteine in comparison with oral acetylcysteine in chronic obstructive pulmonary disease: A randomized single-center study | Kuzmenko, N.; Iaremenko, O.; Dobrianskiy, D.; Ilnytskyi, R.; Gumeniuk, G. |
